Climb Bio Inc
News
(2)April 2026
Climb Bio, Inc. — PRE 14A Filing
# 📄 What This Document Is This is a **PRELIMINARY PROXY STATEMENT (PRE 14A)** for Climb Bio, Inc. Think of it as an invitation and an instruction manual for the company's annual shareholder meeting. It's "preliminary" because the final details might still be tweaked. **👉 In simple terms:** The co
Climb Bio, Inc. — 8-K Filing
# 🧾 What This Document Is This is a **Form 8-K**, a required report companies file with the SEC to announce major, material events that shareholders should know about. Think of it as a "breaking news" alert for investors. This specific 8-K from **Climb Bio, Inc. (CLYM)** is reporting a change in a
Peers in Biotechnology
Vertex Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc.
argenx SE
Alnylam Pharmaceuticals, Inc.
BeOne Medicines AG
Insmed Incorporated
Royalty Pharma plc
BioNTech SE
Roivant Sciences Ltd.
Moderna, Inc.